Visual and semi quantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size

被引:88
作者
Nomori, H
Watanabe, K
Ohtsuka, T
Naruke, T
Suemasu, K
Uno, K
机构
[1] Saiseikai Cent Hosp, Dept Thorac Surg, Minato Ku, Tokyo 1080073, Japan
[2] Nishidai Clin, Tokyo, Japan
关键词
D O I
10.1016/j.athoracsur.2004.07.072
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. While visual assessment is the simplest way to evaluate positron emission tomography (PET) with fluorodeoxyglucose (FDG), faintly positive nodules are often difficult to evaluate. We performed visual and serniquantitative analyses of pulmonary nodules from 1 to 3 cm in size to determine the optimal method of analysis for PET data, especially for faintly positive nodules on visual assessment. Methods. Positron emission tomography data were analyzed for 161 pulmonary nodules from 1 to 3 cm in size (108 malignant and 53 benign nodules). On visual assessment, FDG uptake by the nodules was classified into three grades in comparison with mediastinal blood pool, (ie, definitely positive, faintly positive, and negative). In addition, FDG uptake was measured by the standard uptake value (SUV), the contrast ratio to the contralateral lung (CR-lung), and the contrast ratio to the cerebellum (CR-brain). Cut-off values for each variable were determined from receiver operating characteristics (ROC) curves, and the values were 2.5 for the SUV, 0.4 for the CR-lung, and 0.25 for the CR-brain. Nodules with FDG uptake above these cut-off values were defined as positive in each method. Results. Visual assessment showed definitely positive for 80 nodules (64 malignant and 16 benign), faintly positive for 22 (17 malignant and 5 benign), and negative for 59 nodules (27 malignant and 32 benign). In the 139 nodules that were definitely positive or negative by visual assessment, there were no significant differences of sensitivity and specificity among the four methods (visual assessment, SUV, CR-lung, and CR-brain). In the 17 malignant nodules that were faintly positive, the SUV did not detect any true-positive nodules, but the CR-lung and CR-brain showed 9 and 5 true-positive nodules, respectively, resulting in a significantly higher sensitivity than the SUV (p < 0.001 and p = 0.02, respectively). Fifteen of 17 faintly positive malignant nodules (88%) were histologically well or moderately-differentiated adenocarcinoma. Conclusions. The serniquantitative methods (SUV, CR-lung, and CR-brain) do not improve the efficacy of visual assessment alone for nodules graded as definitely positive or negative. However, faintly positive nodules on visual assessment should be evaluated by the CR-lung or CR-brain rather than the SUV, and are often differentiated adenocarcinomas. (C) 2005 by The Society of Thoracic Surgeons.
引用
收藏
页码:984 / 989
页数:6
相关论文
共 28 条
[1]   Applications of PET in lung cancer [J].
Al-Sugair, A ;
Coleman, RE .
SEMINARS IN NUCLEAR MEDICINE, 1998, 28 (04) :303-319
[2]   Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma [J].
Cremerius, U ;
Fabry, U ;
Neuerburg, J ;
Zimny, M ;
Osieka, R ;
Buell, U .
NUCLEAR MEDICINE COMMUNICATIONS, 1998, 19 (11) :1055-1063
[3]   DIAGNOSTIC EFFICACY OF PET-FDG IMAGING IN SOLITARY PULMONARY NODULES - POTENTIAL ROLE IN EVALUATION AND MANAGEMENT [J].
DEWAN, NA ;
GUPTA, NC ;
REDEPENNING, LS ;
PHALEN, JJ ;
FRICK, MP .
CHEST, 1993, 104 (04) :997-1002
[4]   Analytical decision model for the cost-effective management of solitary pulmonary nodules [J].
Gambhir, SS ;
Shepherd, JE ;
Shah, BD ;
Hart, E ;
Hoh, CK ;
Valk, PE ;
Emi, T ;
Phelps, ME .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2113-2125
[5]   Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions - A meta-analysis [J].
Gould, MK ;
Maclean, CC ;
Kuschner, WG ;
Rydzak, CE ;
Owens, DK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (07) :914-924
[6]   Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions [J].
Gupta, N ;
Gill, H ;
Graeber, G ;
Bishop, H ;
Hurst, J ;
Stephens, T .
CHEST, 1998, 114 (04) :1105-1111
[7]  
Gupta NC, 1996, J NUCL MED, V37, P943
[8]  
HAMBERG LM, 1994, J NUCL MED, V35, P1308
[9]   Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer [J].
Higashi, K ;
Ueda, Y ;
Sakurai, A ;
Wang, XM ;
Xu, LF ;
Murakami, M ;
Seki, H ;
Oguchi, M ;
Taki, S ;
Nambu, Y ;
Tonami, H ;
Katsuda, S ;
Yamamoto, I .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (12) :1778-1785
[10]  
Higashi K, 1998, J NUCL MED, V39, P1016